CUTISS

When patients suffer from disastrous large and deep burns, the ability to quickly, affordably and consistently provide large quantities of skin grafts is essential.

Press release

Related Press

A hand holding a bioreactor to grow vein grafts developed by CSEM and ClexBio

22 February 2024

CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants

The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

(Left to Right) A. Schueller, Founder and CEO; This Egloff, Scientist (cellvie); Charlotte Fonta, Senior R&D Engineer; and Gilles Weder, Head R&BD, Life Science Technologies, CSEM.

3 September 2025

Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use

cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...

11 January 2021

Biospectal Announces Public Beta Launch Of OptiBP™

Biospectal’s OptiBP smartphone app and data platform empowers people worldwide with a medical-grade device integrated directly into their smartphone, enabling instantaneous blood pressure measurement ...